[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 2 sources · 20 days · First seen · Last updated

GLP-1 drug use impact on US clothing retail

Overview

The rising use of GLP-1 weight-loss medications in the United States is significantly impacting the retail clothing sector. Initially, the trend was observed as a driver for increased foot traffic in brick-and-mortar stores, as users experiencing body size changes expressed a greater desire to try on garments in person. Retailers such as Ross Stores reported sales increases linked to this influx, while others began reevaluating dressing-room layouts and styling services to accommodate changing consumer needs.

As the prevalence of GLP-1 drug use grew—reaching an estimated 18% of American adults by mid-2025—the impact on inventory became more pronounced. Major fashion brands have begun reducing their stock of plus-size clothing. For example, H&M reported a near-total absence of 3XL and 4XL sizes in certain new collections compared to previous years, and Mango significantly decreased its inventory of larger dress sizes. This shift in retail strategy coincides with a recorded decline in the U.S. adult obesity rate.

Entities

Don Johnson · Mintel · EDITED · PwC · Ross Stores

Timeline

  1. 21 days ago

    [BUSINESS] 2 sources
    Fashion retailers reduce plus-size clothing amid rise in weight-loss drug use

    U.S. fashion brands like H&M and Mango are cutting plus-size clothing inventory as the use of weight-loss drugs like Ozempic rises and obesity rates decline.

  2. about 1 month ago

    [BUSINESS] 6 sources
    GLP-1 weight‑loss drugs drive surge in in‑store clothing shopping

    Weight‑loss drugs like Mounjaro are prompting U.S. shoppers to return to brick‑and‑mortar clothing stores, with retailers such as David’s Bridal and Ross Stores adjusting sizes and reporting higher foot traffic

Sources

courrierinternational.com · fr.news.yahoo.com